IAF, LLC 13D and 13G filings for Eterna Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-14 8:39 pm Purchase | 2025-03-31 | 13G | Eterna Therapeutics Inc. ERNA | IAF, LLC | 217,028 5.200% | 38,414 (+21.51%) | Filing |
| 2025-02-12 5:54 pm Purchase | 2024-10-29 | 13G | Eterna Therapeutics Inc. ERNA | IAF, LLC | 178,614 5.220% | 140,150 (+364.36%) | Filing |
| 2023-12-20 3:24 pm Purchase | 2023-12-14 | 13G | Eterna Therapeutics Inc. ERNA | IAF, LLC | 38,464 9.990% | 38,464 (New Position) | Filing |